content: <HTML>
  <HEAD>
  <TITLE></TITLE>
  </HEAD>
  <BODY STYLE="font-size: 10pt">
  
  
  <P STYLE="margin: 0; text-align: center; text-indent: 0pt">SECURITIES AND EXCHANGE
  COMMISSION</P>
  
  <P STYLE="margin: 0; text-align: center; text-indent: 0pt">Washington, D.C. 20549</P>
  
  <P STYLE="margin: 0; text-align: center; text-indent: 0pt">&nbsp;</P>
  
  <P STYLE="margin: 0; text-align: center; text-indent: 0pt">FORM 8-K</P>
  
  <P STYLE="margin: 0; text-align: center; text-indent: 0pt">&nbsp;</P>
  
  <P STYLE="margin: 0; text-align: center; text-indent: 0pt">CURRENT REPORT</P>
  
  <P STYLE="margin: 0; text-align: center; text-indent: 0pt">&nbsp;</P>
  
  <P STYLE="margin: 0; text-align: center; text-indent: 0pt">Pursuant to Section 13 or 15(d)</P>
  
  <P STYLE="margin: 0; text-align: center; text-indent: 0pt">of the Securities Exchange Act of 1934</P>
  
  <P STYLE="margin: 0; text-align: center; text-indent: 0pt">&nbsp;</P>
  
  <P STYLE="margin: 0; text-align: center; text-indent: 0pt">Date of Report (date of earliest event
  reported):</P>
  
  <P STYLE="margin: 0; text-align: center; text-indent: 0pt">January 28, 2015</P>
  
  <P STYLE="margin: 0; text-align: center; text-indent: 0pt">&nbsp;&nbsp;</P>
  
  <TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font-size: 10pt; width: 100%">
  <TR STYLE="background-color: white">
      <TD COLSPAN="5" STYLE="margin: 0; text-align: center; text-indent: 0pt; border-bottom: Black 1pt solid"><B>EVENT
      CARDIO GROUP INC.</B></TD></TR>
  <TR STYLE="background-color: white">
      <TD COLSPAN="5" STYLE="margin: 0; text-align: center; text-indent: 0pt"><P STYLE="margin-top: 0; margin-bottom: 0">(Exact name of registrant as specified in its charter)</P>
                                                                              <P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P></TD></TR>
  <TR STYLE="vertical-align: bottom">
      <TD STYLE="margin: 0; text-align: center; text-indent: 0pt; width: 30%; border-bottom: Black 1pt solid"><B>Nevada</B></TD>
      <TD STYLE="margin: 0; text-align: center; text-indent: 0pt; width: 5%; padding-bottom: 1pt">&nbsp;</TD>
      <TD STYLE="margin: 0; text-align: center; text-indent: 0pt; width: 30%; border-bottom: Black 1pt solid"><B>0-52518</B></TD>
      <TD STYLE="margin: 0; text-align: center; text-indent: 0pt; width: 5%; padding-bottom: 1pt">&nbsp;</TD>
      <TD STYLE="margin: 0; text-align: center; text-indent: 0pt; width: 30%; border-bottom: Black 1pt solid"><B>20-8051714</B></TD></TR>
  <TR STYLE="text-align: center; vertical-align: top">
      <TD STYLE="margin: 0; text-indent: 0pt">(State or other jurisdiction of Incorporation)</TD>
      <TD STYLE="margin: 0; text-indent: 0pt">&nbsp;</TD>
      <TD STYLE="margin: 0; text-indent: 0pt">(Commission File Number)</TD>
      <TD STYLE="margin: 0; text-indent: 0pt">&nbsp;</TD>
      <TD STYLE="margin: 0; text-indent: 0pt">(I.R.S. Employer Identification No.)</TD></TR>
  </TABLE>
  <P STYLE="margin: 0; text-align: justify; text-indent: 0pt">&nbsp;</P>
  
  <TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font-size: 10pt; width: 100%">
  <TR STYLE="vertical-align: bottom">
      <TD STYLE="width: 45%; border-bottom: Black 1pt solid"><P STYLE="margin: 0; text-align: center; text-indent: 0pt"><B>2798 Thamesgate Dr.</B></P>
          <P STYLE="margin: 0; text-align: center; text-indent: 0pt"><B>Mississauga, Ontario, Canada</B></P></TD>
      <TD STYLE="width: 10%; padding-bottom: 1pt; text-align: center; line-height: 115%">&nbsp;</TD>
      <TD STYLE="margin: 0; text-align: center; text-indent: 0pt; width: 45%; border-bottom: Black 1pt solid"><B>L4T
      4E8</B></TD></TR>
  </TABLE>
  <P STYLE="margin: 0; text-align: center; text-indent: 0pt">&nbsp;</P>
  
  <P STYLE="margin: 0; text-align: justify; text-indent: 0pt">Check the appropriate box below if the
  Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions
  (see General Instruction A.2. below):</P>
  
  <P STYLE="margin: 0; text-align: justify; text-indent: 0pt">&nbsp;</P>
  
  <P STYLE="margin: 0; text-align: justify; text-indent: 0pt">[ ] Written communications pursuant to Rule 425 under
  the Securities Act (17 CFR 230.425)</P>
  
  <P STYLE="margin: 0; text-align: justify; text-indent: 0pt">[ ] Soliciting material pursuant to Rule 14a-12 under the
  Exchange Act (17&nbsp;&nbsp;&nbsp;CFR 240.14a-12)</P>
  
  <P STYLE="margin: 0; text-align: justify; text-indent: 0pt">[ ] Pre-commencement communications pursuant to Rule 14d-2(b)
  under the Exchange Act (17 CFR 240.14d-2(b))</P>
  
  <P STYLE="margin: 0; text-align: justify; text-indent: 0pt">[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under
  the Exchange Act (17 CFR 240.13e-4(c))</P>
  
  
  <!-- Field: Page; Sequence: 1 -->
      <DIV STYLE="margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
      <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
      <!-- Field: /Page -->
  
  <P STYLE="margin: 0; text-align: justify; text-indent: 0pt"><B>Item 1.01 Entry into a Material Definitive Agreement.</B></P>
  
  <P STYLE="margin: 0; text-align: justify; text-indent: 0pt">&nbsp;</P>
  
  <P STYLE="margin: 0; text-align: justify; text-indent: 20pt">On January 28, 2015, Event Cardio Group
  Inc. (the &#8220;Company&#8221;) entered into a subscription agreement for the sale of 250,000 shares of its common stock and
  warrants to purchase an additional 250,000 shares of common stock for an initial exercise price of $0.20 to Louis Sitaras for
  a purchase price of $25,000. The warrants have an expiration date of January 31, 2016. See Item 3.02 below for additional information
  concerning the transaction, which information is incorporated herein by reference. The subscription agreement with Mr. Sitraras
  is filed as Exhibit 10.1 to this report.</P>
  
  <P STYLE="margin: 0; text-align: justify; text-indent: 20pt">&nbsp;</P>
  
  <P STYLE="margin: 0; text-align: justify; text-indent: 20pt">On January 29, 2015, the Company entered
  into a subscription agreement for the sale of 800,000 shares of its common to Louis P. Solferino for a purchase price of $72,000,
  or $0.09 per share. See Item 3.02 below for additional information concerning the transaction, which information is incorporated
  herein by reference. The subscription agreement with Mr. Solferino is filed as Exhibit 10.2 to this report.</P>
  
  <P STYLE="margin: 0; text-align: justify; text-indent: 20pt">&nbsp;</P>
  
  <P STYLE="margin: 0; text-align: justify; text-indent: 0pt"><B>Item 3.02 Sale of Unregistered Securities.</B></P>
  
  <P STYLE="margin: 0; text-align: justify; text-indent: 20pt">&nbsp;</P>
  
  <P STYLE="margin: 0; text-align: justify; text-indent: 20pt">On January 30, 2015&nbsp;the Company
  issued and sold 250,000 shares of its common stock and warrants to purchase an additional 250,000 shares of common stock for an
  initial exercise price of $0.20 to Louis Sitaras for a purchase price of $25,000 pursuant to a subscription agreement with Mr.
  Sitraras. The warrants have an expiration date of January 31, 2016. Mr. Sitaras represented that he is an accredited investor
  within the meaning of Rule 501 of Regulation D. The issuance and sale of the shares and warrants to Mr. Sitraras was exempt from
  the registration requirements of the Securities Act under Rule 506 of Regulation D of the Securities Act. The certificates evidencing
  the shares and warrants issued to Mr. Sitraras were endorsed with restrictive legends. No broker-dealer or other person received
  a commission in connection with the sale.</P>
  
  <P STYLE="margin: 0; text-align: justify; text-indent: 20pt">&nbsp;</P>
  
  <P STYLE="margin: 0; text-align: justify; text-indent: 20pt">On February 2, 2015&nbsp;the Company
  issued and sold 800,000 shares of its common to Louis P. Solferino for a purchase price of $72,000, or $0.09 per share pursuant
  to a Subscription Agreement with Mr. Solferino. Mr. Solferino represented that he is an accredited investor within the meaning
  of Rule 501 of Regulation D. The issuance and sale of the shares to Mr. Solferino was exempt from the registration requirements
  of the Securities Act under Rule 506 of Regulation D of the Securities Act. The certificate evidencing the shares issued to Mr.
  Solferino was endorsed with restrictive legend. No broker-dealer or other person received a commission in connection with the
  sale.</P>
  
  <P STYLE="margin: 0; text-align: justify; text-indent: 20pt">&nbsp;</P>
  
  <P STYLE="margin: 0; text-align: justify; text-indent: 0pt"><B>Item&nbsp;9.01</B> <B>Financial Statements and Exhibits.</B></P>
  
  
  <P STYLE="margin: 0; text-align: justify; text-indent: 20pt">&nbsp;</P>
  
  <P STYLE="margin: 0; text-align: justify; text-indent: 0pt"><B>(d)</B> <B>Exhibits.</B></P>
  
  
  <P STYLE="margin: 0; text-align: justify; text-indent: 20pt">&nbsp;</P>
  
  <TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="text-align: center; font-weight: bold; vertical-align: bottom">
      <TD COLSPAN="3" STYLE="border-bottom: Black 1pt solid; text-align: center">Exhibit Number</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
      <TD STYLE="border-bottom: Black 1pt solid">Description</TD></TR>
  <TR STYLE="vertical-align: bottom; font-weight: bold">
      <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
      <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
      <TD STYLE="width: 1%; text-align: center">&nbsp;</TD><TD STYLE="width: 18%; text-align: center">10.1</TD><TD STYLE="width: 1%; text-align: center">&nbsp;</TD><TD STYLE="width: 10%">&nbsp;</TD>
      <TD STYLE="width: 70%; text-align: left"><P STYLE="margin: 0; text-align: justify; text-indent: 0pt"><A HREF="ecgi8k020215ex10_1.htm">Subscription Agreement with Louis Sitraras.</A></P></TD></TR>
  <TR STYLE="vertical-align: bottom">
      <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">10.2</TD><TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
      <TD STYLE="margin: 0; text-align: justify; text-indent: 0pt"><A HREF="ecgi8k020215ex10_2.htm">Subscription Agreement with Louis P. Solferino.</A></TD></TR>
  </TABLE>
  
  
  <P STYLE="margin: 0; text-align: justify; text-indent: 20pt">&nbsp;</P>
  
  <P STYLE="margin: 0; text-align: justify; text-indent: 20pt">&nbsp;</P>
  
  <P STYLE="margin-top: 0; margin-bottom: 0; text-align: center">SIGNATURES</P>
  
  <P STYLE="margin: 0; text-align: justify; text-indent: 20pt">&nbsp;</P>
  
  <P STYLE="margin: 0; text-align: justify; text-indent: 20pt">Pursuant to the requirements of the Securities Exchange Act of 1934,
  the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</P>
  
  <P STYLE="margin: 0; text-align: justify; text-indent: 20pt">&nbsp;</P>
  
  <TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font-size: 10pt; width: 100%">
  <TR STYLE="vertical-align: top">
      <TD STYLE="line-height: 115%">&nbsp;</TD>
      <TD COLSPAN="2" STYLE="line-height: 115%">EVENT CARDIO GROUP INC.</TD>
      <TD STYLE="line-height: 115%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
      <TD STYLE="width: 52%; line-height: 115%">&nbsp;</TD>
      <TD STYLE="width: 2%; line-height: 115%">&nbsp;</TD>
      <TD STYLE="width: 35%; line-height: 115%">&nbsp;</TD>
      <TD STYLE="width: 11%; line-height: 115%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
      <TD STYLE="line-height: 115%">Dated: February 2, 2015</TD>
      <TD STYLE="line-height: 115%">By:</TD>
      <TD STYLE="border-bottom: black 1.5pt solid; line-height: 115%">/s/&nbsp;John Bentivoglio</TD>
      <TD STYLE="line-height: 115%">&nbsp;</TD></TR>
  <TR>
      <TD STYLE="vertical-align: top; line-height: 115%">&nbsp;</TD>
      <TD STYLE="vertical-align: top; line-height: 115%">&nbsp;</TD>
      <TD STYLE="vertical-align: bottom; line-height: 115%">John Bentivoglio</TD>
      <TD STYLE="vertical-align: top; line-height: 115%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
      <TD STYLE="line-height: 115%">&nbsp;</TD>
      <TD STYLE="line-height: 115%">&nbsp;</TD>
      <TD STYLE="line-height: 115%">Chief Executive Officer</TD>
      <TD STYLE="line-height: 115%">&nbsp;</TD></TR>
  </TABLE>
  <P STYLE="margin: 0; text-align: justify; text-indent: 20pt"></P>
  
  <!-- Field: Page; Sequence: 2; Options: Last -->
      <DIV STYLE="margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
      <!-- Field: /Page -->
  
  <P STYLE="margin: 0; text-align: justify; text-indent: 20pt"></P>
  
  
  </BODY>
  </HTML>
metadata_documents: [{"type": "8-K", "sequence": "1", "filename": "ecgi8k020215.htm", "secsgml_size_bytes": 12792}]
metadata_filer: {"company-data": {"conformed-name": "Event Cardio Group Inc.", "cik": "0001394130", "assigned-sic": "1000", "irs-number": "208051714", "state-of-incorporation": "NV", "fiscal-year-end": "0930"}, "filing-values": {"form-type": "8-K", "act": "34", "file-number": "000-52518", "film-number": "15566410"}, "business-address": {"street1": "2798 THAMESGATE DR.", "city": "MISSISSAUGA", "state": "A6", "zip": "L4T 4E8", "phone": "289-407-4377"}, "mail-address": {"street1": "2798 THAMESGATE DR.", "city": "MISSISSAUGA", "state": "A6", "zip": "L4T 4E8"}, "former-company": [{"former-conformed-name": "Sunrise Holdings LTD", "date-changed": "20080404"}, {"former-conformed-name": "Sunrise Mining CORP", "date-changed": "20070322"}]}
text: SECURITIES AND EXCHANGE
  COMMISSION
  Washington, D.C. 20549
  FORM 8-K
  CURRENT REPORT
  Pursuant to Section 13 or 15(d)
  of the Securities Exchange Act of 1934
  Date of Report (date of earliest event
  reported):
  January 28, 2015
  EVENT
      CARDIO GROUP INC.
  (Exact name of registrant as specified in its charter)
  Nevada
  0-52518
  20-8051714
  (State or other jurisdiction of Incorporation)
  (Commission File Number)
  (I.R.S. Employer Identification No.)
  2798 Thamesgate Dr.
  Mississauga, Ontario, Canada
  L4T
      4E8
  Check the appropriate box below if the
  Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions
  (see General Instruction A.2. below):
  [ ] Written communications pursuant to Rule 425 under
  the Securities Act (17 CFR 230.425)
  [ ] Soliciting material pursuant to Rule 14a-12 under the
  Exchange Act (17   CFR 240.14a-12)
  [ ] Pre-commencement communications pursuant to Rule 14d-2(b)
  under the Exchange Act (17 CFR 240.14d-2(b))
  [ ] Pre-commencement communications pursuant to Rule 13e-4(c) under
  the Exchange Act (17 CFR 240.13e-4(c))
  Item 1.01 Entry into a Material Definitive Agreement.
  On January 28, 2015, Event Cardio Group
  Inc. (the "Company") entered into a subscription agreement for the sale of 250,000 shares of its common stock and
  warrants to purchase an additional 250,000 shares of common stock for an initial exercise price of $0.20 to Louis Sitaras for
  a purchase price of $25,000. The warrants have an expiration date of January 31, 2016. See Item 3.02 below for additional information
  concerning the transaction, which information is incorporated herein by reference. The subscription agreement with Mr. Sitraras
  is filed as Exhibit 10.1 to this report.
  On January 29, 2015, the Company entered
  into a subscription agreement for the sale of 800,000 shares of its common to Louis P. Solferino for a purchase price of $72,000,
  or $0.09 per share. See Item 3.02 below for additional information concerning the transaction, which information is incorporated
  herein by reference. The subscription agreement with Mr. Solferino is filed as Exhibit 10.2 to this report.
  Item 3.02 Sale of Unregistered Securities.
  On January 30, 2015 the Company
  issued and sold 250,000 shares of its common stock and warrants to purchase an additional 250,000 shares of common stock for an
  initial exercise price of $0.20 to Louis Sitaras for a purchase price of $25,000 pursuant to a subscription agreement with Mr.
  Sitraras. The warrants have an expiration date of January 31, 2016. Mr. Sitaras represented that he is an accredited investor
  within the meaning of Rule 501 of Regulation D. The issuance and sale of the shares and warrants to Mr. Sitraras was exempt from
  the registration requirements of the Securities Act under Rule 506 of Regulation D of the Securities Act. The certificates evidencing
  the shares and warrants issued to Mr. Sitraras were endorsed with restrictive legends. No broker-dealer or other person received
  a commission in connection with the sale.
  On February 2, 2015 the Company
  issued and sold 800,000 shares of its common to Louis P. Solferino for a purchase price of $72,000, or $0.09 per share pursuant
  to a Subscription Agreement with Mr. Solferino. Mr. Solferino represented that he is an accredited investor within the meaning
  of Rule 501 of Regulation D. The issuance and sale of the shares to Mr. Solferino was exempt from the registration requirements
  of the Securities Act under Rule 506 of Regulation D of the Securities Act. The certificate evidencing the shares issued to Mr.
  Solferino was endorsed with restrictive legend. No broker-dealer or other person received a commission in connection with the
  sale.
  Item 9.01
  Financial Statements and Exhibits.
  (d)
  Exhibits.
  Exhibit Number
  Description
  10.1
  Subscription Agreement with Louis Sitraras.
  10.2
  Subscription Agreement with Louis P. Solferino.
  SIGNATURES
  Pursuant to the requirements of the Securities Exchange Act of 1934,
  the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
  EVENT CARDIO GROUP INC.
  Dated: February 2, 2015
  By:
  /s/ John Bentivoglio
  John Bentivoglio
  Chief Executive Officer